Sanofi has paid big bucks to enter the race to develop a new drug for MS. The drug was developed by Principia Biopharma and crosses the blood-brain barrier making it an attractive candidate not only for MS but for the treatment of other neurological disease.
![print-logo](https://images.passle.net/fit-in/300x75/Passle/596df0e43d947619ec025f26/Logo/2017-10-10-9-20-08-905-59dc90c83d94760970999b4e.jpg)
Sanofi Enters the Race to Develop a New Drug for Multiple Sclerosis
![featured image](https://images.passle.net/fit-in/860x860/Passle/596df0e43d947619ec025f26/MediaLibrary/Images/59dd3a7ab00e801e145aaf06/2017-11-10-1-41-07-993-5a05ac733d9476142ce7ac82.jpg)